Collaborative Connected Health (CCH) for PCORI
| Status: | Recruiting |
|---|---|
| Conditions: | Psoriasis |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | February 2015 |
| End Date: | December 2017 |
| Contact: | Brittany M Gibbons, MPH |
| Email: | brittany.gibbons@gmail.com |
| Phone: | 303-501-5527 |
Collaborative Connected Health (CCH): A Pragmatic Trial Evaluating Effectiveness of CCH in Psoriasis Management Compared to In-person Visits.
The investigators propose to evaluate whether an innovative collaborative connected health
(CCH) model increases access to specialists and improves patient outcomes. CCH offers
multiple modalities for patients and primary care providers (PCPs) to access dermatologists
online directly and asynchronously to maximize effectiveness in a real-world setting. CCH
also fosters team care and patient engagement through active sharing of management plans and
multidirectional, informed communication among patients, PCPs, and dermatologists. The
specific aims of the proposal are to (1) determine whether the CCH model results in
equivalent improvements in psoriasis disease severity compared to in-person care, (2)
determine whether the CCH model results in equivalent improvements in quality of life and
mental health compared to in-person care, and (3) assess whether the CCH model provides
better access to care than in-person care.
(CCH) model increases access to specialists and improves patient outcomes. CCH offers
multiple modalities for patients and primary care providers (PCPs) to access dermatologists
online directly and asynchronously to maximize effectiveness in a real-world setting. CCH
also fosters team care and patient engagement through active sharing of management plans and
multidirectional, informed communication among patients, PCPs, and dermatologists. The
specific aims of the proposal are to (1) determine whether the CCH model results in
equivalent improvements in psoriasis disease severity compared to in-person care, (2)
determine whether the CCH model results in equivalent improvements in quality of life and
mental health compared to in-person care, and (3) assess whether the CCH model provides
better access to care than in-person care.
The investigators propose to conduct a 12-month, pragmatic, randomized controlled trial to
evaluate the impact of a collaborative connected health model for psoriasis management
compared to inperson care. The pragmatic trial will compare psoriasis severity,
quality-of-life, mental health, and access-to-care between the two models. We will enroll
300 psoriasis patients from Colorado and California. In addition to recruiting patients from
the general population, we will place a specific emphasis on recruiting psoriasis patients
living in rural and underserved communities. We will also recruit from the full disease
spectrum of mild, moderate, and severe psoriasis patients. We will use an intention-to-treat
approach to analyze outcomes and perform longitudinal data analysis using repeated measures
approach to identify potential differences in the trend over time between the two arms. To
evaluate the utility of CCH for increasing access from patients' and clinicians'
perspective, the study team will conduct key informant interviews and use qualitative
analytical techniques with investigator triangulation and member checking to enhance the
validity of the conclusions.
evaluate the impact of a collaborative connected health model for psoriasis management
compared to inperson care. The pragmatic trial will compare psoriasis severity,
quality-of-life, mental health, and access-to-care between the two models. We will enroll
300 psoriasis patients from Colorado and California. In addition to recruiting patients from
the general population, we will place a specific emphasis on recruiting psoriasis patients
living in rural and underserved communities. We will also recruit from the full disease
spectrum of mild, moderate, and severe psoriasis patients. We will use an intention-to-treat
approach to analyze outcomes and perform longitudinal data analysis using repeated measures
approach to identify potential differences in the trend over time between the two arms. To
evaluate the utility of CCH for increasing access from patients' and clinicians'
perspective, the study team will conduct key informant interviews and use qualitative
analytical techniques with investigator triangulation and member checking to enhance the
validity of the conclusions.
Inclusion Criteria:
- Be age 18 years and older
- Have physician-diagnosed plaque psoriasis
- Have access to internet and a digital camera or a mobile phone with camera features
- Have a primary care provider or the ability to establish primary care
Exclusion Criteria:
We found this trial at
1
site
University of Southern California The University of Southern California is one of the world’s leading...
Click here to add this to my saved trials
